Cargando…

Ebp1 expression in benign and malignant prostate

BACKGROUND: ErbB3-binding protein 1 (Ebp1) is a member of the PA2G4 family of proliferation-regulated proteins that is expressed in multiple malignant and non-malignant cells. ErbB3 and other members of the EGFR family have been implicated in cancer progression, it however remains unknown whether Eb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gannon, Philippe O, Koumakpayi, Ismaël Hervé, Le Page, Cécile, Karakiewicz, Pierre I, Mes-Masson, Anne-Marie, Saad, Fred
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614409/ https://www.ncbi.nlm.nih.gov/pubmed/19025630 http://dx.doi.org/10.1186/1475-2867-8-18

Ejemplares similares

The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
por: Labouba, Ingrid, et al.
Publicado: (2014)

Influence of pH on the Cytotoxic Activity of Inositol Hexakisphosphate (IP6) in Prostate Cancer
por: Betton, Blandine, et al.
Publicado: (2011)

PUMA and NOXA Expression in Tumor-Associated Benign Prostatic Epithelial Cells Are Predictive of Prostate Cancer Biochemical Recurrence
por: Clairefond, Sylvie, et al.
Publicado: (2020)

Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer
por: Koumakpayi, I H, et al.
Publicado: (2010)

Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients
por: Le Page, C, et al.
Publicado: (2006)

IKKε Inhibitor Amlexanox Promotes Olaparib Sensitivity through the C/EBP-β-Mediated Transcription of Rad51 in Castrate-Resistant Prostate Cancer
por: Gilbert, Sophie, et al.
Publicado: (2022)

IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression
por: Péant, Benjamin, et al.
Publicado: (2016)

Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay
por: Labouba, Ingrid, et al.
Publicado: (2015)

Expression of ERBB Family Members as Predictive Markers of Prostate Cancer Progression and Mortality
por: Clairefond, Sylvie, et al.
Publicado: (2021)

High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality
por: Dariane, Charles, et al.
Publicado: (2022)

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: Jiang, You, et al.
Publicado: (2021)

CCAAT/Enhancer Binding Protein-delta (C/EBP-delta) regulates cell growth, migration and differentiation
por: Yu, Xueyan, et al.
Publicado: (2010)

Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired Resistance
por: Cahuzac, Maxime, et al.
Publicado: (2022)

Androgen-Regulated Expression of Arginase 1, Arginase 2 and Interleukin-8 in Human Prostate Cancer
por: Gannon, Philippe O., et al.
Publicado: (2010)

Pre-activation of autophagy impacts response to olaparib in prostate cancer cells
por: Cahuzac, Maxime, et al.
Publicado: (2022)

Hysterectomy for benign conditions: Complications relative to surgical approach and other variables that lead to post-operative readmission within 90 days of surgery
por: Lonky, Neal M, et al.
Publicado: (2017)

Expression of constitutively active 4EBP-1 enhances p27(Kip1 )expression and inhibits proliferation of MCF7 breast cancer cells
por: Jiang, Hong, et al.
Publicado: (2003)

A miRNA expression signature that separates between normal and malignant prostate tissues
por: Carlsson, Jessica, et al.
Publicado: (2011)

Epithelial Na, K-ATPase expression is down-regulated in canine prostate cancer; a possible consequence of metabolic transformation in the process of prostate malignancy
por: Mobasheri, Ali, et al.
Publicado: (2003)

miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
por: Zhang, Dapeng, et al.
Publicado: (2020)

Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype
por: Vieira-Silva, Tânia Soraia, et al.
Publicado: (2019)

High expression of Rab25 contributes to malignant phenotypes and biochemical recurrence in patients with prostate cancer after radical prostatectomy
por: Hu, Chunhui, et al.
Publicado: (2017)

Collapsin response mediator protein 4 promotor methylation level as a potential predictor for diagnosing primary malignant lymphoma of the prostate
por: Chen, Zheng, et al.
Publicado: (2018)

Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
por: Le Page, Cécile, et al.
Publicado: (2010)

Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors
por: Ouellet, Véronique, et al.
Publicado: (2008)

Analysis of personality traits and their influence on the quality of life of postmenopausal women with regard to genetic factors
por: Schneider-Matyka, Daria, et al.
Publicado: (2016)

ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
por: Bikeye, Sandra-Nadia Ngwabyt, et al.
Publicado: (2010)

Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors
por: Diallo, J-S, et al.
Publicado: (2008)

Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada
por: Blanc-Lapierre, Audrey, et al.
Publicado: (2015)

Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer
por: Akoury, Elie, et al.
Publicado: (2019)

LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1
por: Chen, Qi-Hua, et al.
Publicado: (2020)

Modulation of de Novo Lipogenesis Improves Response to Enzalutamide Treatment in Prostate Cancer
por: Lounis, Mohamed Amine, et al.
Publicado: (2020)

Targeting IKKε in Androgen-Independent Prostate Cancer Causes Phenotypic Senescence and Genomic Instability
por: Gilbert, Sophie, et al.
Publicado: (2022)

PRP4K is a HER2-regulated modifier of taxane sensitivity
por: Corkery, Dale P, et al.
Publicado: (2015)

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
por: Le Page, Cécile, et al.
Publicado: (2019)

Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network
por: Grosset, Andrée-Anne, et al.
Publicado: (2019)

Apoptotic response of malignant rhabdoid tumor cells
por: Nocentini, Silvano
Publicado: (2003)

Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression
por: Huang, Liping, et al.
Publicado: (2006)

Problematic Internet Use, health behaviors, depression and eating disorders: a cross-sectional study among Polish medical school students
por: Kożybska, Marta, et al.
Publicado: (2022)

Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours
por: Birch, Ashley H., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_v4etveru8d5i57630h7k0sk232